Atlas Trials

Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease

Clinical trial NCT07431398 · TERMINATED

Trial details

NCT number
NCT07431398
Sponsor
Fulcrum Therapeutics
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2025-12-13
Primary completion
2026-06-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.